These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29218888)

  • 21. Adverse Events Reported to the United States Food and Drug Administration Related to Caffeine-Containing Products.
    Jagim AR; Harty PS; Fischer KM; Kerksick CM; Erickson JL
    Mayo Clin Proc; 2020 Aug; 95(8):1594-1603. PubMed ID: 32753134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
    Alatawi YM; Hansen RA
    Expert Opin Drug Saf; 2017 Jul; 16(7):761-767. PubMed ID: 28447485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts.
    Pierce CE; Bouri K; Pamer C; Proestel S; Rodriguez HW; Van Le H; Freifeld CC; Brownstein JS; Walderhaug M; Edwards IR; Dasgupta N
    Drug Saf; 2017 Apr; 40(4):317-331. PubMed ID: 28044249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of Spontaneously Reported Adverse Events].
    Nakamura M
    Yakugaku Zasshi; 2016; 136(4):549-56. PubMed ID: 27040337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes recommended in adverse event reporting on dietary supplements.
    Landis NT
    Am J Health Syst Pharm; 2001 Jun; 58(11):948, 951, 954. PubMed ID: 11402486
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS).
    Wittayanukorn S; Qian J; Johnson BS; Hansen RA
    J Oncol Pharm Pract; 2017 Mar; 23(2):93-102. PubMed ID: 26661047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Filing Sources after Oral P2Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS).
    Serebruany VL; Cherepanov V; Kim MH; Litvinov O; Cabrera-Fuentes HA; Marciniak TA
    Cardiology; 2017; 138(4):249-253. PubMed ID: 28898876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using Probabilistic Record Linkage of Structured and Unstructured Data to Identify Duplicate Cases in Spontaneous Adverse Event Reporting Systems.
    Kreimeyer K; Menschik D; Winiecki S; Paul W; Barash F; Woo EJ; Alimchandani M; Arya D; Zinderman C; Forshee R; Botsis T
    Drug Saf; 2017 Jul; 40(7):571-582. PubMed ID: 28293864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary supplement adverse events: report of a one-year poison center surveillance project.
    Haller C; Kearney T; Bent S; Ko R; Benowitz N; Olson K
    J Med Toxicol; 2008 Jun; 4(2):84-92. PubMed ID: 18570167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of Natural Language Processing and Network Analysis Techniques to Post-market Reports for the Evaluation of Dose-related Anti-Thymocyte Globulin Safety Patterns.
    Botsis T; Foster M; Arya N; Kreimeyer K; Pandey A; Arya D
    Appl Clin Inform; 2017 Apr; 8(2):396-411. PubMed ID: 28447098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database.
    Hauben M; Hung EY; Hanretta KC; Bangalore S; Snow V
    Drug Saf; 2015 Nov; 38(11):1127-39. PubMed ID: 26242615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary supplements: physician knowledge and adverse event reporting.
    Cellini M; Attipoe S; Seales P; Gray R; Ward A; Stephens M; Deuster PA
    Med Sci Sports Exerc; 2013 Jan; 45(1):23-8. PubMed ID: 22811037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse event monitoring and multivitamin-multimineral dietary supplements.
    Woo JJ
    Am J Clin Nutr; 2007 Jan; 85(1):323S-324S. PubMed ID: 17209219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Term Coverage of Dietary Supplements Ingredients in Product Labels.
    Wang Y; Adam TJ; Zhang R
    AMIA Annu Symp Proc; 2016; 2016():2053-2061. PubMed ID: 28269965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases.
    Nomura K; Takahashi K; Hinomura Y; Kawaguchi G; Matsushita Y; Marui H; Anzai T; Hashiguchi M; Mochizuki M
    Drug Des Devel Ther; 2015; 9():3031-41. PubMed ID: 26109846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
    Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
    Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardizing drug adverse event reporting data.
    Wang L; Jiang G; Li D; Liu H
    Stud Health Technol Inform; 2013; 192():1101. PubMed ID: 23920875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. iDISK: the integrated DIetary Supplements Knowledge base.
    Rizvi RF; Vasilakes J; Adam TJ; Melton GB; Bishop JR; Bian J; Tao C; Zhang R
    J Am Med Inform Assoc; 2020 Apr; 27(4):539-548. PubMed ID: 32068839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.